1) Patients who show serious hypersensitivity such as anaphylaxis or angioedema to SUGANON or other dipeptidyl peptidase 4 (DPP4) inhibitors.
2) Patients with type I diabetes or diabetic ketoacidosis.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education